RAF1 and cancer: Rocaglamide A, derived from medicinal plants, have been demonstrated to interact directly with PHB1 and thus inhibit the interaction of PHB1 with Raf-1, impeding Raf-1/ERK signaling cascades and significantly suppressing cancer cell metastasis (40).